Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" report has ...
SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Genesis MedTech Group announced today that the Food and Drug Administration (FDA) has approved the Chocolate Touch® Drug-coated Balloon PTA Catheter, developed ...
DUBLIN--(BUSINESS WIRE)--The "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By Application, By End ...
The global percutaneous transluminal angioplasty (PTA) balloons market was valued at approximately US$ 2.1 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.4%, ...
Dublin, Oct. 14, 2022 (GLOBE NEWSWIRE) -- The "Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market By Product, By Delivery Platform, By Compliance, By Balloon Material: Global ...
Covidien's Fortrex percutaneous transluminal angioplasty balloon catheter--Courtesy of Covidien Covidien ($COV) today announced FDA 510(k) clearance for its Fortrex ...
MINNEAPOLIS --Expanding its extensive portfolio of lesion-specific solutions for the interventional treatment of peripheral artery disease, Medtronic, Inc. announced today that the Pacific Plus ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
“Unveiling Future Possibilities: An In-depth Exploration of the ‘Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Trends from 2023 to 2032’ Report” Embark on an ...
Chronic atherosclerotic peripheral arterial disease commonly causes narrowing or blockage of lower limb arteries. Symptoms include intermittent claudication, ischaemic rest pain, ulceration and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback